We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$836B
AUM Growth
+$19.8B
Cap. Flow
-$11.8B
Cap. Flow %
-1.42%
Top 10 Hldgs %
35.57%
Holding
3,089
New
135
Increased
1,850
Reduced
836
Closed
113

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.01B
2
AVGO icon
Broadcom
AVGO
+$1.49B
3
GEV icon
GE Vernova
GEV
+$1.19B
4
IP icon
International Paper
IP
+$1.05B
5
SCHW
Charles Schwab
SCHW
+$952M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.31B
2
CEG icon
Constellation Energy
CEG
+$1.94B
3
QCOM icon
Qualcomm
QCOM
+$1.74B
4
NVDA icon
NVIDIA
NVDA
+$1.71B
5
CRM icon
Salesforce
CRM
+$1.5B

Sector Composition

Rank Sector Weight
1 Technology 33.98%
2 Healthcare 14.89%
3 Financials 10.35%
4 Consumer Discretionary 10.11%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNGO icon
2851
Bionano Genomics
BNGO
$13.8M
$48K ﹤0.01%
1,173
PROK icon
2852
ProKidney
PROK
$304M
$48K ﹤0.01%
19,194
+8,709
+83% +$23.4K
VTNR
2853
DELISTED
Vertex Energy, Inc
VTNR
$47K ﹤0.01%
49,500
-15,476
-24% -$18.2K
CCLD icon
2854
CareCloud
CCLD
$104M
$46K ﹤0.01%
23,700
WKHS icon
2855
Workhorse Group
WKHS
$33.7M
$46K ﹤0.01%
192
+82
+75% +$43K
POWW icon
2856
Outdoor Holding Co
POWW
$267M
$45K ﹤0.01%
26,303
BMTX
2857
DELISTED
BM Technologies, Inc.
BMTX
$45K ﹤0.01%
19,800
BRN icon
2858
Barnwell Industries
BRN
$13.9M
$43K ﹤0.01%
18,200
RFL icon
2859
Rafael Holdings
RFL
$103M
$43K ﹤0.01%
29,731
RVMDW icon
2860
Revolution Medicines Inc Warrant
RVMDW
$124M
$43K ﹤0.01%
606,180
-1,256
-0.2% -$260
WVVI icon
2861
Willamette Valley Vineyards
WVVI
$11.5M
$43K ﹤0.01%
10,850
QIPT
2862
DELISTED
Quipt Home Medical
QIPT
$42K ﹤0.01%
12,829
BKSY icon
2863
BlackSky Technology
BKSY
$1.3B
$41K ﹤0.01%
4,764
+856
+22% +$8.03K
OPI
2864
DELISTED
Office Properties Income Trust
OPI
$41K ﹤0.01%
19,941
-11,771
-37% -$25.6K
QMCO icon
2865
Quantum Corp
QMCO
$864M
$41K ﹤0.01%
5,030
LLAP
2866
DELISTED
Terran Orbital Corporation
LLAP
$41K ﹤0.01%
49,970
+22,038
+79% +$23.6K
CRBU icon
2867
Caribou Biosciences
CRBU
$169M
$40K ﹤0.01%
23,952
+572
+2% +$1.83K
LIDR icon
2868
AEye
LIDR
$61.4M
$40K ﹤0.01%
+20,196
New +$40.2K
LTRX icon
2869
Lantronix
LTRX
$275M
$40K ﹤0.01%
11,200
MOND
2870
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$40K ﹤0.01%
16,541
+5,266
+47% +$11.7K
TDUP icon
2871
ThredUp
TDUP
$405M
$39K ﹤0.01%
22,381
GRTS
2872
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$39K ﹤0.01%
62,700
-24,127
-28% -$20.4K
IPSC icon
2873
Century Therapeutics
IPSC
$355M
$38K ﹤0.01%
+14,882
New +$47K
NAUT icon
2874
Nautilus Biotechnolgy
NAUT
$114M
$38K ﹤0.01%
16,078
NRDY icon
2875
Nerdy
NRDY
$93.7M
$38K ﹤0.01%
22,656
+5,408
+31% +$11.9K

Similar funds

T. Rowe Price Associates's Q2 2024 Portfolio in Review

As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
  • T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
  • T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
  • T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
  • T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
  • T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
  • T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.